世界のがん診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Cancer Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1065 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、がん診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プラットフォームベース、機器ベース）、用途別市場規模（乳がん、肺がん、大腸がん、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん診断の市場動向 ・企業の競争状況、市場シェア ・がん診断の種類別市場規模（プラットフォームベース、機器ベース） ・がん診断の用途別市場規模（乳がん、肺がん、大腸がん、その他） ・がん診断の北米市場規模2016-2027（アメリカ、カナダ） ・がん診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Becton, Dickinson and Company、GE Healthcare、Abbott、Roche、Thermo Fisher Scientific、Agilent Technologies、Illumina、Siemens Healthcare、C.R. Bard） ・結論

Market Analysis and Insights: Global Cancer Diagnostics Market
The global Cancer Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Diagnostics market.

Global Cancer Diagnostics Scope and Market Size
Cancer Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Platform-based
Instrument-based

Segment by Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Becton, Dickinson and Company
GE Healthcare
Abbott
Roche
Thermo Fisher Scientific
Agilent Technologies
Illumina
Siemens Healthcare
C.R. Bard

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Platform-based
1.2.3 Instrument-based
1.3 Market by Application
1.3.1 Global Cancer Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cancer Diagnostics Market Perspective (2016-2027)
2.2 Cancer Diagnostics Growth Trends by Regions
2.2.1 Cancer Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Diagnostics Industry Dynamic
2.3.1 Cancer Diagnostics Market Trends
2.3.2 Cancer Diagnostics Market Drivers
2.3.3 Cancer Diagnostics Market Challenges
2.3.4 Cancer Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cancer Diagnostics Players by Revenue
3.1.1 Global Top Cancer Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Cancer Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Diagnostics Revenue
3.4 Global Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Diagnostics Revenue in 2020
3.5 Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Diagnostics Breakdown Data by Type
4.1 Global Cancer Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Cancer Diagnostics Forecasted Market Size by Type (2022-2027)

5 Cancer Diagnostics Breakdown Data by Application
5.1 Global Cancer Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Cancer Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cancer Diagnostics Market Size (2016-2027)
6.2 North America Cancer Diagnostics Market Size by Type
6.2.1 North America Cancer Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Cancer Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Cancer Diagnostics Market Size by Type (2016-2027)
6.3 North America Cancer Diagnostics Market Size by Application
6.3.1 North America Cancer Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Cancer Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Cancer Diagnostics Market Size by Application (2016-2027)
6.4 North America Cancer Diagnostics Market Size by Country
6.4.1 North America Cancer Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Cancer Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Cancer Diagnostics Market Size (2016-2027)
7.2 Europe Cancer Diagnostics Market Size by Type
7.2.1 Europe Cancer Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Cancer Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Cancer Diagnostics Market Size by Type (2016-2027)
7.3 Europe Cancer Diagnostics Market Size by Application
7.3.1 Europe Cancer Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Cancer Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Cancer Diagnostics Market Size by Application (2016-2027)
7.4 Europe Cancer Diagnostics Market Size by Country
7.4.1 Europe Cancer Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Cancer Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cancer Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific Cancer Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific Cancer Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific Cancer Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cancer Diagnostics Market Size (2016-2027)
9.2 Latin America Cancer Diagnostics Market Size by Type
9.2.1 Latin America Cancer Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Cancer Diagnostics Market Size by Application
9.3.1 Latin America Cancer Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Cancer Diagnostics Market Size by Country
9.4.1 Latin America Cancer Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cancer Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa Cancer Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa Cancer Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa Cancer Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Becton, Dickinson and Company
11.1.1 Becton, Dickinson and Company Company Details
11.1.2 Becton, Dickinson and Company Business Overview
11.1.3 Becton, Dickinson and Company Cancer Diagnostics Introduction
11.1.4 Becton, Dickinson and Company Revenue in Cancer Diagnostics Business (2016-2021)
11.1.5 Becton, Dickinson and Company Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Cancer Diagnostics Introduction
11.2.4 GE Healthcare Revenue in Cancer Diagnostics Business (2016-2021)
11.2.5 GE Healthcare Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Cancer Diagnostics Introduction
11.3.4 Abbott Revenue in Cancer Diagnostics Business (2016-2021)
11.3.5 Abbott Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Cancer Diagnostics Introduction
11.4.4 Roche Revenue in Cancer Diagnostics Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Cancer Diagnostics Introduction
11.5.4 Thermo Fisher Scientific Revenue in Cancer Diagnostics Business (2016-2021)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Agilent Technologies
11.6.1 Agilent Technologies Company Details
11.6.2 Agilent Technologies Business Overview
11.6.3 Agilent Technologies Cancer Diagnostics Introduction
11.6.4 Agilent Technologies Revenue in Cancer Diagnostics Business (2016-2021)
11.6.5 Agilent Technologies Recent Development
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Cancer Diagnostics Introduction
11.7.4 Illumina Revenue in Cancer Diagnostics Business (2016-2021)
11.7.5 Illumina Recent Development
11.8 Siemens Healthcare
11.8.1 Siemens Healthcare Company Details
11.8.2 Siemens Healthcare Business Overview
11.8.3 Siemens Healthcare Cancer Diagnostics Introduction
11.8.4 Siemens Healthcare Revenue in Cancer Diagnostics Business (2016-2021)
11.8.5 Siemens Healthcare Recent Development
11.9 C.R. Bard
11.9.1 C.R. Bard Company Details
11.9.2 C.R. Bard Business Overview
11.9.3 C.R. Bard Cancer Diagnostics Introduction
11.9.4 C.R. Bard Revenue in Cancer Diagnostics Business (2016-2021)
11.9.5 C.R. Bard Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cancer Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Platform-based
Table 3. Key Players of Instrument-based
Table 4. Global Cancer Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Cancer Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cancer Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Cancer Diagnostics Market Share by Regions (2016-2021)
Table 8. Global Cancer Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Cancer Diagnostics Market Share by Regions (2022-2027)
Table 10. Cancer Diagnostics Market Trends
Table 11. Cancer Diagnostics Market Drivers
Table 12. Cancer Diagnostics Market Challenges
Table 13. Cancer Diagnostics Market Restraints
Table 14. Global Cancer Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Cancer Diagnostics Market Share by Players (2016-2021)
Table 16. Global Top Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Diagnostics as of 2020)
Table 17. Ranking of Global Top Cancer Diagnostics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Cancer Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cancer Diagnostics Product Solution and Service
Table 21. Date of Enter into Cancer Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Table 25. Global Cancer Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Cancer Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Cancer Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Cancer Diagnostics Revenue Market Share by Application (2016-2021)
Table 29. Global Cancer Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Cancer Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Cancer Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Becton, Dickinson and Company Company Details
Table 62. Becton, Dickinson and Company Business Overview
Table 63. Becton, Dickinson and Company Cancer Diagnostics Product
Table 64. Becton, Dickinson and Company Revenue in Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 65. Becton, Dickinson and Company Recent Development
Table 66. GE Healthcare Company Details
Table 67. GE Healthcare Business Overview
Table 68. GE Healthcare Cancer Diagnostics Product
Table 69. GE Healthcare Revenue in Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 70. GE Healthcare Recent Development
Table 71. Abbott Company Details
Table 72. Abbott Business Overview
Table 73. Abbott Cancer Diagnostics Product
Table 74. Abbott Revenue in Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 75. Abbott Recent Development
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Cancer Diagnostics Product
Table 79. Roche Revenue in Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 80. Roche Recent Development
Table 81. Thermo Fisher Scientific Company Details
Table 82. Thermo Fisher Scientific Business Overview
Table 83. Thermo Fisher Scientific Cancer Diagnostics Product
Table 84. Thermo Fisher Scientific Revenue in Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Thermo Fisher Scientific Recent Development
Table 86. Agilent Technologies Company Details
Table 87. Agilent Technologies Business Overview
Table 88. Agilent Technologies Cancer Diagnostics Product
Table 89. Agilent Technologies Revenue in Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 90. Agilent Technologies Recent Development
Table 91. Illumina Company Details
Table 92. Illumina Business Overview
Table 93. Illumina Cancer Diagnostics Product
Table 94. Illumina Revenue in Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 95. Illumina Recent Development
Table 96. Siemens Healthcare Company Details
Table 97. Siemens Healthcare Business Overview
Table 98. Siemens Healthcare Revenue in Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 99. Siemens Healthcare Recent Development
Table 100. C.R. Bard Company Details
Table 101. C.R. Bard Business Overview
Table 102. C.R. Bard Cancer Diagnostics Product
Table 103. C.R. Bard Revenue in Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 104. C.R. Bard Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Platform-based Features
Figure 3. Instrument-based Features
Figure 4. Global Cancer Diagnostics Market Share by Application: 2020 VS 2027
Figure 5. Breast Cancer Case Studies
Figure 6. Lung Cancer Case Studies
Figure 7. Colorectal Cancer Case Studies
Figure 8. Others Case Studies
Figure 9. Cancer Diagnostics Report Years Considered
Figure 10. Global Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Cancer Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Cancer Diagnostics Market Share by Regions: 2020 VS 2027
Figure 13. Global Cancer Diagnostics Market Share by Regions (2022-2027)
Figure 14. Global Cancer Diagnostics Market Share by Players in 2020
Figure 15. Global Top Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Diagnostics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Cancer Diagnostics Revenue in 2020
Figure 17. Global Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Figure 18. Global Cancer Diagnostics Revenue Market Share by Type (2022-2027)
Figure 19. North America Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Cancer Diagnostics Market Share by Type (2016-2027)
Figure 21. North America Cancer Diagnostics Market Share by Application (2016-2027)
Figure 22. North America Cancer Diagnostics Market Share by Country (2016-2027)
Figure 23. United States Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cancer Diagnostics Market Share by Type (2016-2027)
Figure 27. Europe Cancer Diagnostics Market Share by Application (2016-2027)
Figure 28. Europe Cancer Diagnostics Market Share by Country (2016-2027)
Figure 29. Germany Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cancer Diagnostics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Cancer Diagnostics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Cancer Diagnostics Market Share by Region (2016-2027)
Figure 39. China Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cancer Diagnostics Market Share by Type (2016-2027)
Figure 47. Latin America Cancer Diagnostics Market Share by Application (2016-2027)
Figure 48. Latin America Cancer Diagnostics Market Share by Country (2016-2027)
Figure 49. Mexico Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cancer Diagnostics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Cancer Diagnostics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Cancer Diagnostics Market Share by Country (2016-2027)
Figure 55. Turkey Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Becton, Dickinson and Company Revenue Growth Rate in Cancer Diagnostics Business (2016-2021)
Figure 59. GE Healthcare Revenue Growth Rate in Cancer Diagnostics Business (2016-2021)
Figure 60. Abbott Revenue Growth Rate in Cancer Diagnostics Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Cancer Diagnostics Business (2016-2021)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Cancer Diagnostics Business (2016-2021)
Figure 63. Agilent Technologies Revenue Growth Rate in Cancer Diagnostics Business (2016-2021)
Figure 64. Illumina Revenue Growth Rate in Cancer Diagnostics Business (2016-2021)
Figure 65. Siemens Healthcare Revenue Growth Rate in Cancer Diagnostics Business (2016-2021)
Figure 66. C.R. Bard Revenue Growth Rate in Cancer Diagnostics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---